Mirion Technologies (MIR) Competitors

Bio-Rad Laboratories (NYSE:BIO.B) and Mirion Technologies (NYSE:MIR) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Does the media favor BIO.B or MIR?

In the previous week, Mirion Technologies had 9 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 10 mentions for Mirion Technologies and 1 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 1.05 beat Mirion Technologies' score of 0.66 indicating that Bio-Rad Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Rad Laboratories	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mirion Technologies	3 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals have more ownership in BIO.B or MIR?

0.0% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are held by institutional investors. 28.4% of Bio-Rad Laboratories shares are held by insiders. Comparatively, 2.2% of Mirion Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Does the MarketBeat Community prefer BIO.B or MIR?

Bio-Rad Laboratories received 115 more outperform votes than Mirion Technologies when rated by MarketBeat users. However, 76.92% of users gave Mirion Technologies an outperform vote while only 57.60% of users gave Bio-Rad Laboratories an outperform vote.

Company	Underperform	Outperform
Bio-Rad Laboratories	Outperform Votes 125 57.60%	Underperform Votes 92 42.40%
Mirion Technologies	Outperform Votes 10 76.92%	Underperform Votes 3 23.08%

Which has better earnings and valuation, BIO.B or MIR?

Mirion Technologies has lower revenue, but higher earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Rad Laboratories	$2.56B	3.73	-$637.32M	-$10.36	-32.32
Mirion Technologies	$821.30M	3.61	-$96.90M	-$0.41	-31.84

Do analysts prefer BIO.B or MIR?

Mirion Technologies has a consensus price target of $14.00, suggesting a potential upside of 7.24%. Given Mirion Technologies' higher possible upside, analysts plainly believe Mirion Technologies is more favorable than Bio-Rad Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Rad Laboratories	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Mirion Technologies	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50

Which has more volatility and risk, BIO.B or MIR?

Bio-Rad Laboratories has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, Mirion Technologies has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500.

Is BIO.B or MIR more profitable?

Mirion Technologies has a net margin of -7.80% compared to Bio-Rad Laboratories' net margin of -51.73%. Mirion Technologies' return on equity of 3.81% beat Bio-Rad Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Rad Laboratories	-51.73%	3.77%	2.68%
Mirion Technologies	-7.80%	3.81%	2.21%

Summary

Mirion Technologies beats Bio-Rad Laboratories on 12 of the 18 factors compared between the two stocks.